Alyeska Investment Group’s GE HealthCare GEHC Stock Holding History

Alyeska Investment Group’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,120,000	Closed	-$79.7M	–	714
2026 Q1	$79.7M	Sell	1,120,000 -1,057,563	-49%	-$83.4M	0.23%	126
2025 Q4	$179M	Buy	2,177,563 +1,093,012	+101%	+$85.2M	0.5%	37
2025 Q3	$81.4M	Buy	1,084,551 +522,059	+93%	+$38.9M	0.25%	116
2025 Q2	$41.7M	Buy	+562,492	New	+$39.2M	0.15%	176
2024 Q4	–	Sell	-7,031	Closed	-$660K	–	595
2024 Q3	$660K	Buy	+7,031	New	+$590K	﹤0.01%	479
2024 Q1	–	Sell	-127,483	Closed	-$9.86M	–	523
2023 Q4	$9.86M	Buy	+127,483	New	+$8.93M	0.07%	262
2023 Q3	–	Sell	-205,329	Closed	-$16.7M	–	544
2023 Q2	$16.7M	Buy	+205,329	New	+$16.4M	0.12%	215

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Alyeska Investment Group's GEHC Position: Q2 2026 in Review

Alyeska Investment Group sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 1,120,000 shares — an estimated $79.7M sold.

Alyeska Investment Group first reported a position in GEHC in Q2 2023 and held it in 7 quarters. The position peaked at $179M in Q4 2025. 1,232 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Alyeska Investment Group reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
Alyeska Investment Group sold 1,120,000 GE HealthCare shares in Q2 2026, an estimated $79.7M.
Alyeska Investment Group first reported a position in GE HealthCare in Q2 2023 and held it in 7 quarters.
Alyeska Investment Group's GE HealthCare position peaked at $179M in Q4 2025.
1,232 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.